1. Home
  2. YRD vs PMVP Comparison

YRD vs PMVP Comparison

Compare YRD & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Yiren Digital Ltd.

YRD

Yiren Digital Ltd.

HOLD

Current Price

$0.62

Market Cap

88.4M

Sector

Finance

ML Signal

HOLD

Logo PMV Pharmaceuticals Inc.

PMVP

PMV Pharmaceuticals Inc.

SELL

Current Price

$1.34

Market Cap

81.3M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
YRD
PMVP
Founded
2012
2013
Country
China
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
88.4M
81.3M
IPO Year
2015
2020

Fundamental Metrics

Financial Performance
Metric
YRD
PMVP
Price
$0.62
$1.34
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
★ $4.20
AVG Volume (30 Days)
118.2K
★ 692.2K
Earning Date
09-30-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$426.63
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$1.86
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.36
$1.02
52 Week High
$6.14
$1.91

Technical Indicators

Market Signals
Indicator
YRD
PMVP
Relative Strength Index (RSI) 33.50 42.49
Support Level N/A $1.32
Resistance Level $1.05 $1.35
Average True Range (ATR) 0.09 0.14
MACD -0.04 -0.04
Stochastic Oscillator 39.56 7.26

Price Performance

Historical Comparison
YRD
PMVP

About YRD Yiren Digital Ltd.

Yiren Digital Ltd is an AI-powered platform providing a comprehensive suite of financial and lifestyle services in China. Its mission is to elevate customers' financial well-being and enhance their quality of life by delivering digital financial services, tailor-made insurance solutions, and premium lifestyle services. The company supports clients at various growth stages, addressing financing needs arising from consumption and production activities, while aiming to augment the overall well-being and security of individuals, families, and businesses.

About PMVP PMV Pharmaceuticals Inc.

PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. The key product candidate, rezatapopt, is designed to be an orally available small molecule that structurally corrects the mutant p53 protein with the Y220C mutation. Currently, the product candidates are undergoing preclinical and clinical testing, and company relies on third parties for the manufacture after marketing approvals.

Share on Social Networks: